関連する実験動画
Updated: May 17, 2026

10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
細菌性髄膜炎の治療における進歩
Diederik van de Beek1, Matthijs C Brouwer, Guy E Thwaites
1Department of Neurology, Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands. d.vandebeek@amc.uva.nl
Lancet (London, England)
|November 13, 2012
まとめ
細菌性髄膜炎は重大な脅威となり,抗生物質耐性の増大が治療を複雑にする. このレビューは,抗生物質の有効性の最適化と,より良い患者の結果のための補助療法評価を探求しています.
科学分野:
- 感染症 感染症は感染症です.
- 微生物学 微生物学とは
- 薬理学 薬理学とは
背景:
- 細菌性髄膜炎は,高い死亡率と発症率を有する重症感染症である.
- 多剤耐性細菌の出現は,標準的な抗生物質治療の有効性を損なう.
- デキサメタゾンのような補助療法は,特に資源の限られた環境では,議論の余地のある有効性を持っています.
研究 の 目的:
- バクテリア性髄膜炎によって引き起こされる治療上の課題を見直す.
- 薬剤耐性細菌に対する抗生物質の有効性を最適化するための戦略に焦点を当てること.
- 現行および新興の補助療法の役割について議論する.
主な方法:
- 細菌性髄膜炎の治療に関する既存の研究の文献レビュー.
- 抗生物質耐性傾向とその治療効果への影響の分析.
- デキサメタゾン,グリセロール,パラセタモール,低体温症を含む補助療法に関する臨床データの評価.
主要な成果:
- 早期の抗生物質治療は不可欠ですが,多剤耐性病原菌によってますます挑戦されています.
- フルオロキノノロンなどの新しい抗生物質の有効性は,さらなる臨床検証を必要とする.
- デキサメタゾンなどの補助的な抗炎症治療は,効果が限られており,特定の集団では無効である.
結論:
- バクテリア性髄膜炎は,依然として重要な治療上の課題であり,進化を遂げています.
- 抗生物質耐性に対抗するための抗生物質戦略の最適化は不可欠です.
- 患者のアウトカムを改善するために,特に高負荷地域では,新しい補助療法に関するさらなる研究が必要である.
関連する概念動画
Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...

